keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tirzepatide sodium salt (LY3298176 sodium salt) is a GIP and GLP-1 receptor agonist with neuroprotective activity and can be used to treat obesity.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 60,500 |
5 mg | 在庫あり | ¥ 158,500 |
10 mg | 在庫あり | ¥ 259,500 |
25 mg | 在庫あり | ¥ 388,000 |
50 mg | 在庫あり | ¥ 532,500 |
100 mg | 在庫あり | ¥ 718,500 |
説明 | Tirzepatide sodium salt (LY3298176 sodium salt) is a GIP and GLP-1 receptor agonist with neuroprotective activity and can be used to treat obesity. |
In vitro | Under high glucose-induced conditions, treatment of SHSY5Y cells with Tirzepatide sodium salt at concentrations ranging from 0 to 0.4 μM for 7 days resulted in significant upregulation of CREB and BDNF mRNA expression. Additionally, it increased the protein levels of pAkt, MAP2, GAP43, AGBL4, GLUT4, SORBS1, and Bcl-2 while decreasing the protein level of BAX[1]. |
In vivo | In diet-induced obese (DIO) mice, Tirzepatide sodium salt (10 nM/kg, subcutaneous injection) reduced body weight and food consumption. It decreased glucose, insulin, leptin, and C-peptide levels[2]. |
別名 | LY-3298176 sodium salt, Tirzepatide sodium salt(2023788-19-2 free base) |
分子量 | N/A |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tirzepatide sodium salt GPCR/G Protein Glucagon Receptor LY-3298176 sodium salt Tirzepatide sodium salt(2023788-19-2 free base) Inhibitor inhibitor inhibit